Bath & Body Works Stock (BBWI) Slips as Analysts Remain Cautious Despite Strong Earnings

Bath & Body Works (BBWI) stock was down on Thursday alongside a new surge of analysts’ updates after the specialty retailer’s latest earnings report.

Let’s dig into the updated BBWI coverage from Wall Street’s top analysts below.

• J.P. Morgan analyst Matthew Boss reiterated a Hold rating and cut his price target to $22 from $23, representing a potential 2.87% downside.
• TD Cowen analyst Jonna Kim maintained a Buy rating and a $26 price target, suggesting a possible 14.79% upside.
• Citi analyst Paul Lejuez kept a Hold rating and a $25 price target, implying a 10.38% upside.
• Goldman Sachs analyst Kate McShane stuck with a Hold rating but boosted her price target to $26 from $17.
• UBS analyst Jay Sole reiterated a Hold rating and a $22 price target.
• Barclays analyst Adrienne Yih maintained a Hold rating but raised her price target to $25 from $21.
• Deutsche Bank analyst Krisztina Katai kept a Hold rating but increased her price target to $23 from $22, suggesting a 1.55% upside.

Wells Fargo analyst Ike Boruchow argued that investors should buy Bath & Body Works stock on the post-earnings pullback. He also said the company’s turnaround plan is “right where it should be.” Boruchow has a $29 price target for BBWI stock, representing a possible 29.18% upside for the shares.

Bath & Body Works Stock Movement Today

Bath & Body Works stock fell 2.43% on Thursday but was still up 12.74% year-to-date. The shares have also fallen 32.72% over the past 12 months.

Is Bath & Body Works Stock a Buy, Sell, or Hold?

Turning to Wall Street, the analysts’ consensus rating for Bath & Body Works is Hold, based on three Buy and nine Hold ratings over the past three months. With that comes an average BBWI stock price target of $25.30, representing a potential 13.15% upside for the shares.